¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"base projection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • delusional projection
    ¸Á»óÅõ»ç
  • eccentric projection
    Ä¡¿ìÄ£°¨°¢, ¿¬°ü°¨°¢
  • half-axial projection
    ¹ÝÃ༺Åõ»ç
  • lateral projection
    Ãø¸éÅõ¿µ(¹ý)
  • light projection
    ºû¹æÇâ¾Ë¾Æº¸±â, ±¤Åõ»ç½Äº°´É
  • lordotic projection
    ôÃßÀü¸¸Åõ»ç, ôÃß¾Õ±ÁÀÌÃÔ¿µ
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • mesioeccentric projection
    Æí±Ù½ÉÅõ¿µ(¹ý)
  • oblique projection
    ºñ½ºµëÅõ¿µ(¹ý)
  • optic canal projection
    ½Ã(°¢)½Å°æ°üÅõ»ç¹ý
  • orthoradial projection
    Á¤¹æ¼±¹æÇâÅõ¿µ(¹ý)
  • posteroanterior projection
    µÚ¾ÕÅõ¿µ(¹ý)
  • projection
    1. Åõ»ç 2. Åõ¿µ
  • projection fiber
    Åõ»ç¼¶À¯
  • projection image
    Åõ»ç¿µ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • visual projection area
    ½Ã°¢Åõ»ç±¸¿ª
  • convergence-projection theory
    ÆøÁÖÅõ»ç¼³
  • projection center
    Åõ»çÁßÃß
  • delusional projection
    ¸Á»óÅõ»ç
  • eccentric projection
    (¢¡referred sensation) ¿¬°ü°¨°¢
  • projection fiber
    Åõ»ç¼¶À¯
  • projection image
    Åõ»ç¿µ»ó
  • lateral projection
    Ãø¸éÅõ¿µ¹ý
  • light projection
    ºû¹æÇâ¾Ë¾Æº¸±â, ±¤Åõ»ç½Äº°´É
  • lordotic projection
    ôÃßÀü¸¸Åõ»ç, ôÃß¾Õ±ÁÀÌÃÔ¿µ
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • mesioeccentric projection
    Æí±Ù½ÉÅõ¿µ(¹ý)
  • projection neuron
    Åõ»ç½Å°æ¼¼Æ÷
  • oblique projection
    ºñ½ºµëÅõ¿µ¹ý
  • optic canal projection
    ½Ã°¢½Å°æ°üÅõ»ç¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • projection tract
    Åõ»ç·Î(÷áÞÒÖØ).
  • retinal projection
    ¸Á¸·Åõ¿µ
  • specific thalamocortical projection nuclei
    Ư¼ö½Ã»óÇÇÁúÅõ»çÇÙ±º(÷åâ¨ãÊßÉ ù«òõ÷áÞÒú·ÏØ).
  • spherical projection
    ±¸¸éÅõ»ç
  • stereographic projection
    ÀÔü ÃÔ¿µÅõ»ç
  • thalamocortical projection system
    ½Ã»óÇÇÁúÅõ»ç°è.
  • visual projection area
    ½Ã°¢Åõ»ç¾ß (¡­÷áÞÒå¯).
  • acid-base buffer system
    »ê¿°±â¿ÏÃæ°è
  • acid-base compensation
    »ê¿°±â º¸»ó
  • acid-base indicator
    »ê¿°±âÁö½Ã¾à
  • alveolar base
    Ä¡Á¶±âÀú(öÍðËÐñî¼).
  • apical base
    (Ä¡)±Ù÷(´Ü)±âÀú(¡­Ðñî¼).
  • arytenoid base
    ¸ð»Ô¿¬°ñ¹Ù´Ú
  • base
    ¿°±â
  • base (lining) applicators
    ÀÌÀå¿ë ±â±¸(ìÀíûéÄÐïÎý).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • conjugate acid-base pair
    ¦ÁöÀº »ê¿°±â½Ö(ß«ç¤Ðñäª)
  • general acid-base catalysis
    ÀϹÝ(ìéÚõ) »ê-¿°±â Ã˸Å(ß«-ç¤ÐñõºØÚ)ÀÛ¿ë
  • Hoogsten base pairs
    ÈŽºÆ¾ ¿°±â ½Ö(äª)
  • Lewis acid-base catalysis
    ·çÀ̽º »ê-¿°±â(ß«.ç¤Ðñ) Ã˸ÅÀÛ¿ë(ç¤Ðñ õºØÚÚãëë)
  • Lewis base
    ·çÀ̽º¿°±â(ç¤Ðñ)
  • long-chain base
    ±ä»ç½½ ¿°(ç¤)
  • minor base
    ¼Ò¼ö ¿°±â(á³â¦ç¤Ðñ)
  • modified base
    ¼ö½Ä¿°±â(áóãÞç¤Ðñ)
  • nearest-neighbor base frequency analysis
    ÃÖ±ÙÁ¢ ¿°±â ºóµµºÐ¼®(õÌÐÎïÈç¤ÐñÞºÓøÝÂà°)
  • nitrogenous base
    Áú¼Ò¿°±â(òòáÈç¤Ðñ)
  • nonnucleic acid base
    ºñÇÙ»ê ¿°±â(Þªú·ß«ç¤Ðñ)
  • odd base
    Ȧ ¿°±â(ç¤Ðñ)
  • rare base
    Èñ±Í(ýüÏþ) ¿°±â(ç¤Ðñ)
  • rotational base substitution
    ¼±È¸ ¿°±â ġȯ(àÁüÞç¤ÐñöÇüµ)
  • Schiff base
    ½¬ÇÁ ¿°±â(ç¤Ðñ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BE   1) Bacterial Endocarditis
  2) Base Excess
  3) Below the Elbo...
bp base pair; ¿°±â½Ö
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
A/B acid-base ratio
AIDSDRUGS clinical trials of acquired immunodeficiency drugs [MEDLARS data base]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BL Base-line
DB Data Base
DBMS Data Base Management System
KB Knowledge Base
NCDB National Cancer Data Base
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sensory projection
    °¨°¢ Åõ»ç
    °¨°¢ÀÌ ±×°ÍÀ» ÀÏÀ¸Å°´Â ÀÚ±ØÀÌ ÀÖ´Â °÷¿¡ ÀϾ´Â °ÍÀ¸·Î ÆÇ´ÜÇÏ´Â ±â´É.
  • sensory projection neuron
    °¨°¢ Åõ»ç ´º¿ì·±
  • spinal cord nociceptive projection cell
    ô¼ö À¯ÇØ ¼ö¿ë¼º Åõ»ç ¼¼Æ÷
  • spinal nociceptive projection cell
    ô¼ö À¯ÇØ Åõ»ç ¼¼Æ÷
  • stereographic projection
    ÀÔü ÃÔ¿µ Åõ»ç
  • topographically organized projection
    ±¹¼Ò ÇØºÎÀûÀ¸·Î Á¶Á÷È­µÈ µ¹±â
  • transorbital projection
    °æ¾È¿Í Åõ»ç¹ý
  • acid-base
    »ê ¿°±â
  • acid-base balance disturbance
    »ê ¿°±â ÆòÇü ÀÌ»ó
    »ê°ú ¿°±âÀÇ ÆòÇüÀÌ ±úÁø »óÅÂ.
  • acid-base compensation
    »ê ¿°±â º¸»ó
  • acid-base indicator
    »ê ¿°±â Áö½Ã¾à
  • alveolar base
    Ä¡Á¶ ±âÀú
  • base applicator
    ÀÌÀå¿ë ±â±¸
  • base line
    ±â¼±, ±âÀú¼±, ¹ÙÅÁ¼±
    ¹ÌÁ¤ÀÇ ¾çÀ̳ª °ªÀ» ÃøÁ¤ ¶Ç´Â ÆòÁ¤ÇÏ´Â µ¥ ¾²ÀÌ´Â ±âº»ÀÇ ¾ç ¶Ç´Â °ª.
  • base line shift
    ±âÁؼ± º¯À§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Fischer projection formula <biochemistry> Of sugars, representations, by projection, of cyclic sugars, or derivatives thereof, in which the carbon chain is depicted vertically.
The lowest-numbered asymmetric carbon atom (C-1 in aldoses; C-2 in 2-ketoses, e.g., fructose) is drawn at the top, and the rest of the carbon atoms of the chain are drawn in sequence below the top carbon atom.
For each carbon atom, depicted in projection as lying in the plane of the paper, the carbon-to-carbon bond(s), which actually point away from the viewer, are drawn as vertical lines. The left-hand and right-hand bonds of each carbon atom, which actually point toward the viewer, are, in projection, depicted as horizontal lines.
The conventions for the Fischer formulas of cyclic sugars are as follows: 1) if the highest-numbered asymmetric carbon atom has its OH (or its replacement) lying to the right, as is the 2-OH of d-glyceraldehyde, the sugar has the d configuration; if the OH is to the left, the sugar has the l configuration. 2) On the anomeric carbon atom (C-1 in the aldoses; C-2 in the 2-ketoses), an OH or substituted OH that lies to the right, with the OH of the highest-numbered asymmetric carbon atom also to the right is defined to be a; if it is to the left, with the OH of the highest-numbered carbon atom still to the right, it is b; the reverse applies if the latter OH is to the left. 3) The orientation of a terminal CH2OH group in the aldoses carries no configurational significance, as it contains no asymmetric carbon atom.
(05 Mar 2000)
lateral projection Radiographic projection with the X-ray beam in a coronal plane.
(05 Mar 2000)
frog-leg lateral projection A lateral projection of the femoral neck made with the thigh maximally abducted.
(05 Mar 2000)
acid-base balance The normal balance between acid and base in the blood plasma, expressed in the hydrogen ion concentration or pH, resulting from the relative amounts of acidic and basic materials ingested and produced by body metabolism, compared to the relative amounts of acidic and basic materials excreted from the body and consumed by body metabolism; the normal state of acid-base balance is not one of neutrality, with equal concentrations of hydrogen and hydroxyl ions, but a more alkaline state with a certain excess of hydroxyl ions.
Synonym: acid-base equilibrium.
(05 Mar 2000)
acid-base equilibrium A condition in which the net rate of acid or alkali production by the body is balanced by the net rate of acid or alkali excretion from the body, resulting in a stable concentration of hydrogen ions in the body fluids.
(12 Dec 1998)
acid-base imbalance Disturbances in the acid-base equilibrium of the body.
(12 Dec 1998)
acrylic resin base A form made of acrylic resin molded to conform to the tissues of the alveolar process and used to support the teeth of a prosthesis.
(05 Mar 2000)
aldehyde base An obsolete term for an imide.
(05 Mar 2000)
anterior cranial base The portion of the internal base of the skull, anterior to the sphenoidal ridges and limbus, in which the frontal lobes of the brain rest.
Synonym: fossa cranii anterior, anterior cranial base.
(05 Mar 2000)
Bandrowski's base <chemical> Reported cause of anaphylactic reaction.
Synonym: n',n'-bis(4-aminophenyl)-2,5-diamino-1,4-quinonediimine
(26 Jun 1999)
base <chemistry> The nonacid part of a salt, a substance that combines with acids to form salts, a substance that dissociates to give hydroxide ions in aqueous solutions, a substance whose molecule or ion can combine with a proton (hydrogen ion), a substance capable of donating a pair of electrons (to an acid) for the formation of a coordinate covalent bond.
(13 Nov 1997)
base analogue <biochemistry> A chemical which resembles a nucleotide base. They can substitute the Purine and pyrimidine bases that normally appear in DNA, despite minor differences in structure. May be used for inducing mutations, including point mutations.
For example: 5 bromouracil can replace thymine or 2 aminopurine replace adenine.
(13 Nov 1997)
base composition <biochemistry> In reference to nucleic acid, the proportion of the total bases consisting of guanine plus cytosine or thymine plus adenine base pairs.
Usually expressed as a guanine + cytosine (G+C) value, for example 60% G+C.
(09 Oct 1997)
base deficit A decrease in the total concentration of blood buffer base, indicative of metabolic acidosis or compensated respiratory alkalosis.
(05 Mar 2000)
base dissociation constant <chemistry> This is the equilibrium constant for the reaction in which a weak base breaks apart in water to form its conjugate acid and hydroxide ion.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • full base
    ¸¸·ç
  • home base
    º»·ç
  • naval base
    ÇØ±º±âÁö
  • power base
    ¼¼·Â ±â¹Ý;ÁöÁö ¸ðü
  • prisoners base
    Áø »©¾Ñ±â ³îÀÌ
  • rate base
    (ÀâÁöÀÇ)º¸Áõ ºÎ¼ö(À̸¦ ¹ÙÅÁÀ¸·Î ±¤°í¿ä±ÝÀÌ Á¤ÇØÁü)
  • relay base
    Áß°è¼®
  • rocket base
    ¹Ì»çÀÏ ±âÁö
  • secondary base
    2·ç
  • time base
    ½Ã°£Ãà
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á